BUSCADOR RECOLECTA

Dataset.

Dataset related to article: Metabolic Effects of Aripiprazole and Olanzapine Multiple-Dose Treatment in a Randomised Crossover Clinical Trial in Healthy Volunteers: Association with Pharmacogenetics

Digital.CSIC. Repositorio Institucional del CSIC
oai:digital.csic.es:10261/245504
Digital.CSIC. Repositorio Institucional del CSIC
  • Koller, Dora
  • Almenara, Susana
  • Mejía, Gina
  • Saiz-Rodríguez, Miriam
  • Zubiaur, Pablo
  • Román, Manuel
  • Ochoa, Dolores
  • Navares-Gómez, Marcos
  • Santos-Molina, Elena
  • Pintos-Sánchez, Elena
  • Abad-Santos, Francisco
The data generated or analysed during this study are obtained included in the clinical trial registry name, URL and registration number: TREATMENT-HV; EUDRACT 2018-000744-26; https://eudract.ema. europa.eu/. File1 Adverse events after the treatment with antipsychotics, Short-term treatment with aripiprazole and olanzapine had a significant influence on the metabolic parameters. However, it seems that aripiprazole provokes less severe metabolic changes., European Comission ITN Treatment H2020-MSCA-ITN-721236, Peer reviewed
 
Proyecto: EC/H2020/721236

DOI: http://hdl.handle.net/10261/245504
Digital.CSIC. Repositorio Institucional del CSIC
oai:digital.csic.es:10261/245504

HANDLE: http://hdl.handle.net/10261/245504
Digital.CSIC. Repositorio Institucional del CSIC
oai:digital.csic.es:10261/245504
 
Ver en: http://hdl.handle.net/10261/245504
Digital.CSIC. Repositorio Institucional del CSIC
oai:digital.csic.es:10261/245504
Go back
×

1 Versiones

Digital.CSIC. Repositorio Institucional del CSIC
oai:digital.csic.es:10261/245504
Dataset. 2021

DATASET RELATED TO ARTICLE: METABOLIC EFFECTS OF ARIPIPRAZOLE AND OLANZAPINE MULTIPLE-DOSE TREATMENT IN A RANDOMISED CROSSOVER CLINICAL TRIAL IN HEALTHY VOLUNTEERS: ASSOCIATION WITH PHARMACOGENETICS

Digital.CSIC. Repositorio Institucional del CSIC
  • Koller, Dora
  • Almenara, Susana
  • Mejía, Gina
  • Saiz-Rodríguez, Miriam
  • Zubiaur, Pablo
  • Román, Manuel
  • Ochoa, Dolores
  • Navares-Gómez, Marcos
  • Santos-Molina, Elena
  • Pintos-Sánchez, Elena
  • Abad-Santos, Francisco
The data generated or analysed during this study are obtained included in the clinical trial registry name, URL and registration number: TREATMENT-HV; EUDRACT 2018-000744-26; https://eudract.ema. europa.eu/. File1 Adverse events after the treatment with antipsychotics, Short-term treatment with aripiprazole and olanzapine had a significant influence on the metabolic parameters. However, it seems that aripiprazole provokes less severe metabolic changes., European Comission ITN Treatment H2020-MSCA-ITN-721236, Peer reviewed

Proyecto: EC/H2020/721236
HANDLE: http://hdl.handle.net/10261/245504


Help guide

1106